Key result
Iloprost boosts myocardial contractility and limits lipid peroxidation during ischemia-reperfusion in isolated hearts.
Why the study?
Myocardial ischemia-reperfusion injury continues to occur during open heart surgery, prompting experimental evaluation of whether the prostacyclin analogue iloprost can mitigate this injury.
Does preischemic perfusion with iloprost reduce myocardial ischemia-reperfusion injury in isolated guinea pig hearts?
Does preischemic perfusion with iloprost reduce myocardial ischemia-reperfusion injury in isolated guinea pig hearts?
In an ex vivo guinea pig heart model, preischemic administration of iloprost demonstrated cardioprotective effects against ischemia-reperfusion injury by improving contractility and attenuating lipid peroxidation.
Answers are grounded in this paper and cite their sources.
Findings hypothesis-generating for iloprost in ischemia-reperfusion injury; prospective human studies needed before clinical consideration.
Myocardial ischemia-reperfusion injury continues to be observed during open heart surgery. Various experimental models have been developed to overcome this injury and to increase postoperative prognosis. This study was conducted to assess the effect that iloprost, a prostacyclin analogue, can have on myocardial ischemia-reperfusion injury. We evaluated tissue damage by measuring the levels of malonyldialdehyde (MDA), glutathione, and nitric oxide (NO) in tissue and perfusates. In this study, 20 guinea pig hearts were prepared by using the modified Langendorff perfusion apparatus to form control (n = 10) and experimental study groups (n = 10). Following a preischemic period of perfusion and an ischemic period of 20 minutes, control hearts were perfused with Krebs–Henseleit solution. In the experimental group, iloprost (0.45 μg/kg per hour) was included in the perfusates for the last 10 minutes of the preischemic phase. Following cardiac stabilization, heart rate (pulse/min), contractility (mm), and aortic pressure (mmHg) values were recorded at the end of preischemia, postischemia, and reperfusion. Perfusate and tissue analyses for glutathione, MDA, and NO levels were made in each group at the end of experiments. Iloprost was found to have protective effects against myocardial ischemia by means of increased myocardial contractility, decreased tissue/perfusate glutathione levels and inhibited rise of tissue/perfusate MDA observed in the iloprost-treated experimental group. Future investigations on myocardial ischemia-reperfusion injury must evaluate iloprost-related mechanisms.
No takes yet. Share an insight, caveat, or question.
Tümer et al. (2019) studied Myocardial ischemia-reperfusion injury (n=20). Iloprost vs. Krebs-Henseleit solution alone was evaluated on Myocardial contractility, heart rate, aortic pressure, and tissue/perfusate levels of malonyldialdehyde (MDA), glutathione, and nitric oxide (NO). Iloprost increased myocardial contractility, decreased glutathione levels, and inhibited the rise of MDA in 20 isolated guinea pig hearts.
Synapse has enriched 10 related papers. Consider them for comparative context: